As we identified ADAM10 as a key protease to induce CD44 dependent transcriptional upregulation of MMP14 and MMP2, inhibition of CD44 cleavage by ADAM10 might be a future translational approach to prevent tumor cell migration and invasion. Here, ADAM10 is linked to neoplasm.